A Phase 1b Trial of a Combination of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers

Trial Profile

A Phase 1b Trial of a Combination of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 21 Feb 2017

At a glance

  • Drugs Binimetinib (Primary) ; Fluorouracil; Folinic acid; Irinotecan
  • Indications Colorectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Feb 2017 Status changed from suspended to recruiting.
    • 29 Nov 2016 Status changed from recruiting to suspended.
    • 25 May 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top